Cargando…
Development of superior antibodies against the S-protein of SARS-Cov-2 using macrocyclic epitopes
One of the proven methods to prevent and inhibit viral infections is to use antibodies to block the initial Receptor Binding Domain (RBD) of SARS-CoV-2 S protein and avoid its binding with the host cells. Thus, developing these RBD-targeting antibodies would be a promising approach for treating the...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier B.V. on behalf of King Saud University.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662835/ https://www.ncbi.nlm.nih.gov/pubmed/34909055 http://dx.doi.org/10.1016/j.arabjc.2021.103631 |